Novo makes unsolicited bid for Ablynx

Novo Nordisk A/S disclosed on 8 January that it has made a second unsolicited bid for Ablynx NV – this time for €2.6 billion.The Ablynx board has responded saying that the proposal "fundamentally undervalues the company and its future."

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

Belgium